Clinical trialNCT06958796RecruitingPhase 4Interventional

Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)

SponsorCamille N. Kotton, MDEnrollment80CytomegalovirusKidney Transplant; ComplicationsLiver Transplant ComplicationsOrgan TransplantSimultaneous Liver-Kidney Transplantation; Complications

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being done to find out if administering CytoGam® after the end of standardly prescribed preventive antiviral treatment can help transplant recipients with a high risk for developing late CMV disease after a liver and/or kidney transplant.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Camille Kotton, MD, FIDSA, FAST
Massachusetts General Hospital
Principal Investigator
clinicaltrials.gov ↗
David Wojciechowski, DO
University of Texas Southwestern Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Massachusetts General Hospital
Boston, Massachusetts, United States
Camille Kotton, MD
Recruiting
University of Texas Southwestern
Dallas, Texas, United States
David Wojciechowski, DO
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Cytomegalovirus Immune Globulin Intravenous monthly for three months

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Nov 2025
Primary completion: 30 Dec 2027
Completion: 31 May 2028
Last update posted: 22 Dec 2025
Registered enrollment: 80
Registry id: NCT06958796

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.